The global peripherally inserted central catheters market is estimated to be valued at US$ 857.7 million in 2022 and is expected to exhibit a CAGR of 6.9% during the forecast period (2023-2030).
A PICC line is a central line that is introduced from the periphery. A central line (or central venous catheter) functions similarly to an intravenous line in the body. A PICC line, in contrast to standard intravenous fluid, is thicker and can withstand more wear and tear. It’s also substantially longer and penetrates the vein deeper. A peripherally implanted central catheter is useful for patients who require intravenous antibiotic treatment for weeks, chemotherapy and blood testing through the line, intravenous nourishment, and frequent blood transfusions. There are a variety of central catheters designed for peripheral insertion, including those with one, two, or more lumens.
Request Sample Report + All Related Graphs & Charts:
https://www.coherentmarketinsights.com/insight/request-sample/4048
Businesses in every industry have felt the effects of the global coronavirus (COVID-19) outbreak and lockdown. One industry hit hard by the pandemic is the private healthcare industry. The lockdowns in several nations have imposed a financial hardship on the independent medical industry. The safety of patients with various conditions, as well as a decline in outpatient visits, present significant difficulties for the healthcare industry. In addition, the pandemic has stunted the expansion of many businesses’ healthcare divisions around the world and hampered the research, manufacturing, and distribution of pharmaceuticals. The result has been a disturbance in the supply chain and the shutdown of many factories, with the exception of those producing necessities. Indirectly, the COVID-19 pandemic has damaged production and demand; directly, it has disrupted distribution routes; and financially, it has affected businesses and financial markets. Lockdowns have caused disruptions in the supply chain and manufacturing activities in many countries, including India, China, the United States, and others. But many nations, including Thailand, Indonesia, and Singapore, struggle to get life-saving medications and medical supplies to their citizens.
As a result, the global market for peripherally placed central catheters is anticipated to increase at a slower rate than normal over the projected period due to the impact of the coronavirus (COVID-19) pandemic.
Top Key Players:
★ Abbott Laboratories
★ Bayer AG
★ Boehringer Ingelheim GmbH
★ GlaxoSmithKline plc
★ AstraZeneca PLC
★ OncoGenex Pharmaceuticals Inc.
★ Pfizer Inc.
★ AVEO Pharmaceuticals Inc.
★ CYTOKINETICS INC.
The global market for peripherally placed central catheters is anticipated to develop as a result of rising product introductions by main players and rising inorganic growth strategies, like acquisition.
The increasing number of partnerships between major industry players is expected to be a driving force for the market in the predicted period. For example, Vygon (UK) Ltd. bought the Italian company Pilot in December 2019; Pilot specializes in ECG central venous catheter tip location and navigation systems. Vygone will now offer a wider selection of intravascular treatment devices, including central venous catheters, implanted ports, and PICC lines, thanks to the acquisition.
The expansion of the worldwide peripherally implanted central catheters market is moreover anticipated to be driven by the concentration of market leading competitors on product launches. Examples include the 2018 introduction of the Arrowg+ard Blue Advance Peripherally Inserted Central Catheters by the American company Teleflex at the International Congress on Vascular Access 2018 in Copenhagen, Denmark (PICC). Catheter-related problems such occlusion, phlebitis, and fibrin sheath deposition on catheter surfaces are less likely to occur as a result of using this product.
Lack of knowledge of patients’ central lines is anticipated to restrain growth of the worldwide peripherally placed central catheters market over the forecast period. According to one study published in July 2020 titled “Awareness of Central Venous Catheters: A Patient Safety Study,” some doctors may not realize their patients have central lines.
We Offer Customized Report, Click:
https://www.coherentmarketinsights.com/insight/request-customization/4048
Some of the most important companies in the world market for peripherally placed central catheters are: AngioDynamics Inc., B. Braun Melsungen AG, Becton, Dickinson and Company, Teleflex Incorporated., Argon Medical Devices, Inc., Cook Medical Inc., ICU Medical, Inc., Medical Components, Inc., Access Vascular, and Vygon (UK) Ltd.
Purchasing the Peripherally Inserted Central Catheters Market:
➣ Outlook for the worldwide Peripherally Inserted Central Catheters market in both developed and emerging markets, both now and in the future.
➣ Both the market segment with the largest projected share and the market segment with the highest CAGR throughout the projection period.
➣ Countries and regions anticipated to experience the fastest development throughout the projected period.
➣ The most recent innovations, market shares, and business tactics used by the key market participants.
➣ Study examines emerging market trends as well as the likelihood that various trends will impact expansion.
➣ Analysis also discusses the factors, challenges, and opportunities that will have a significant impact on the global Peripherally Inserted Central Catheters industry.
➣ Research includes a detailed analysis of market statistics as well as historical and current growth conditions in order to provide futuristic growth estimates.
Purchase This Complete Business Report:
https://www.coherentmarketinsights.com/insight/buy-now/4048
Table of Content
Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Peripherally Inserted Central Catheters Market Size Analysis from 2023 to 2030
11.6 COVID-19 Outbreak: Peripherally Inserted Central Catheters Industry Impact
Chapter 2 Global Peripherally Inserted Central Catheters Competition by Types, Applications, and Top Regions and Countries
2.1 Global Peripherally Inserted Central Catheters (Volume and Value) by Type
2.3 Global Peripherally Inserted Central Catheters (Volume and Value) by Regions
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.2 Regional Production Market Analysis
Chapter 4 Global Peripherally Inserted Central Catheters Sales, Consumption, Export, Import by Regions (2017-2023)
Chapter 5 North America Peripherally Inserted Central Catheters Market Analysis
Chapter 6 East Asia Peripherally Inserted Central Catheters Market Analysis
Chapter 7 Europe Peripherally Inserted Central Catheters Market Analysis
Chapter 8 South Asia Peripherally Inserted Central Catheters Market Analysis
Chapter 9 Southeast Asia Peripherally Inserted Central Catheters Market Analysis
Chapter 10 Middle East Peripherally Inserted Central Catheters Market Analysis
Chapter 11 Africa Peripherally Inserted Central Catheters Market Analysis
Chapter 12 Oceania Peripherally Inserted Central Catheters Market Analysis
Chapter 13 South America Peripherally Inserted Central Catheters Market Analysis
Chapter 14 Company Profiles and Key Figures in Peripherally Inserted Central Catheters Business
Chapter 15 Global Peripherally Inserted Central Catheters Market Forecast (2023-2030)
Chapter 16 Conclusions
Explore More Related Insights:
Pediatric interventional cardiology market
Electrophysiology devices market
Hemodynamic monitoring systems market
About Us:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having sales office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 57 countries worldwide. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Contact Us:
Mr. Shah
Coherent Market Insights Pvt Ltd,
533 Airport Boulevard, Suite 400, Burlingame
CA 94010, United States
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
JAPAN: +81-50-5539-1737
INDIA: +91-848-285-0837